LS
Leelyn Smith’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.38M | Buy |
18,206
+299
| +2% | +$55.5K | 0.55% | 43 |
|
2025
Q1 | $3.75M | Sell |
17,907
-345
| -2% | -$72.3K | 0.67% | 40 |
|
2024
Q4 | $3.24M | Sell |
18,252
-338
| -2% | -$60.1K | 0.58% | 43 |
|
2024
Q3 | $3.67M | Sell |
18,590
-29
| -0.2% | -$5.73K | 0.66% | 41 |
|
2024
Q2 | $3.19M | Sell |
18,619
-597
| -3% | -$102K | 0.62% | 43 |
|
2024
Q1 | $3.5M | Sell |
19,216
-457
| -2% | -$83.2K | 0.7% | 42 |
|
2023
Q4 | $3.05M | Sell |
19,673
-548
| -3% | -$84.9K | 0.67% | 42 |
|
2023
Q3 | $3.01M | Sell |
20,221
-482
| -2% | -$71.8K | 0.74% | 38 |
|
2023
Q2 | $2.79M | Sell |
20,703
-898
| -4% | -$121K | 0.67% | 42 |
|
2023
Q1 | $3.44M | Sell |
21,601
-71
| -0.3% | -$11.3K | 0.88% | 29 |
|
2022
Q4 | $3.5M | Buy |
21,672
+843
| +4% | +$136K | 0.96% | 23 |
|
2022
Q3 | $2.8M | Sell |
20,829
-439
| -2% | -$58.9K | 0.97% | 22 |
|
2022
Q2 | $3.26M | Sell |
21,268
-552
| -3% | -$84.5K | 0.84% | 33 |
|
2022
Q1 | $3.54M | Sell |
21,820
-7
| -0% | -$1.14K | 0.92% | 24 |
|
2021
Q4 | $2.96M | Sell |
21,827
-707
| -3% | -$95.7K | 0.79% | 32 |
|
2021
Q3 | $2.43M | Buy |
22,534
+141
| +0.6% | +$15.2K | 0.7% | 39 |
|
2021
Q2 | $2.52M | Sell |
22,393
-113
| -0.5% | -$12.7K | 0.74% | 39 |
|
2021
Q1 | $2.44M | Buy |
22,506
+754
| +3% | +$81.6K | 0.73% | 37 |
|
2020
Q4 | $2.33M | Buy |
21,752
+401
| +2% | +$43K | 0.75% | 35 |
|
2020
Q3 | $1.87M | Sell |
21,351
-134
| -0.6% | -$11.7K | 0.66% | 38 |
|
2020
Q2 | $2.11M | Sell |
21,485
-414
| -2% | -$40.6K | 0.87% | 23 |
|
2020
Q1 | $1.6M | Buy |
21,899
+2,353
| +12% | +$172K | 0.85% | 29 |
|
2019
Q4 | $1.73K | Buy |
+19,546
| New | +$1.73K | 0.83% | 26 |
|